The first-year growth response to growth hormone treatment predicts the long-term prepubertal growth response in children
Open Access
- 12 January 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Medical Informatics and Decision Making
- Vol. 9 (1), 1
- https://doi.org/10.1186/1472-6947-9-1
Abstract
Background: Pretreatment auxological variables, such as birth size and parental heights, are important predictors of the growth response to GH treatment. For children with missing pretreatment data, published prediction models cannot be used. The objective was to construct and validate a prediction model for children with missing background data based on the observed first-year growth response to GH. The accuracy and reliability of the model should be comparable with our previously published prediction model relying on pretreatment data. The design used was mathematical curve fitting on observed growth response data from children treated with a GH dose of 33 μg/kg/d. Methods: Growth response data from 162 prepubertal children born at term were used to construct the model; the group comprised of 19% girls, 80% GH-deficient and 23% born SGA. For validation, data from 205 other children fulfilling the same inclusion and treatment criteria as the model group were used. The model was also tested on data from children born prematurely, children from other continents and children receiving a GH dose of 67 μg/kg/d. Results: The GH response curve was similar for all children, but with an individual amplitude. The curve SD score depends on an individual factor combining the effect of dose and growth, the 'Response Score', and time on treatment, making prediction possible when the first-year growth response is known. The prediction interval (± 2 SDres) was ± 0.34 SDS for the second treatment year growth response, corresponding to ± 1.2 cm for a 3-year-old child and ± 1.8 cm for a 7-year-old child. For the 1–4-year prediction, the SDres was 0.13 SDS/year and for the 1–7-year prediction it was 0.57 SDS (i.e. < 0.1 SDS/year). Conclusion: The model based on the observed first-year growth response on GH is valid worldwide for the prediction of up to 7 years of prepubertal growth in children with GHD/ISS, born AGA/SGA and born preterm/term, and can be used as an aid in medical decision making.This publication has 32 references indexed in Scilit:
- Models predicting the growth response to growth hormone treatment in short children independent of GH status, birth size and gestational ageBMC Medical Informatics and Decision Making, 2007
- Age at Growth Hormone Therapy Start and First-Year Responsiveness to Growth Hormone Are Major Determinants of Height Outcome in Idiopathic Short StatureHormone Research in Paediatrics, 2007
- Swedish population‐based longitudinal reference values from birth to 18 years of age for height, weight and head circumferenceActa Paediatrica, 2002
- The Potential of Prediction Models Based on Data from KIGS as Tools to Measure Responsiveness to Growth HormoneHormone Research in Paediatrics, 2001
- Plenary LecturesHormone Research in Paediatrics, 1999
- Growth Response to Growth Hormone (GH) Treatment Relates to Serum Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein-3 in Short Children with Various GH Secretion CapacitiesJournal of Clinical Endocrinology & Metabolism, 1997
- Survey of growth hormone treatment practices by 251 pediatric endocrinologistsJournal of Clinical Endocrinology & Metabolism, 1995
- Final Height in a Large Cohort of Dutch Patients with Growth Hormone Deficiency Treated with Growth HormoneHormone Research, 1995
- Seasonality in lower leg length velocity in prepubertal childrenActa Paediatrica, 1994
- An Update of the Swedish Reference Standards for Weight, Length and Head Circumference at Birth for Given Gestational Age (1977‐1981)Acta Paediatrica, 1991